GNG11 and non-small cell lung carcinoma: Through these levels of analysis, we have demonstrated that module 2 provides a molecular space for interpreting chemical–protein interactions and drug target identification, suggesting that the chemokine signaling pathway and several GNG11 involved interactions are potential therapeutic targets for NSCLC.